Anna Schurich
- Hepatology top 0.5%
- Immunology top 1%
- Immune Cell Function and Interaction 29
- T-cell and B-cell Immunology 11
- Immunotherapy and Immune Responses 10
- Epidemiology top 2%
- Cytomegalovirus and herpesvirus research 6
- Hepatitis B Virus Studies 5
- Oncology top 5%
- CAR-T cell therapy research 8
- Cancer Immunotherapy and Biomarkers 4
- Virology top 5%
-
- Viral gastroenteritis research and epidemiology 2
- Co-authors
- Mala K. MainiPatrick KennedyDimitra PeppaLaura J. PallettUpkar S. GillL. MiccoPercy A. KnolleGaia Nebbia
- Cited by
- HepatologyImmunologyEpidemiology
- Partner nations
- United KingdomGermanyCanada
In The Last Decade
Anna Schurich
37 papers receiving 3.2k citations
Peers
Comparison fields: 5 of 88
- Hepatology 1.2k
- Immunology 1.8k
- Epidemiology 1.6k
- Oncology 608
- Virology 85
Countries citing papers authored by Anna Schurich
This map shows the geographic impact of Anna Schurich's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Schurich with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Schurich more than expected).
Fields of papers citing papers by Anna Schurich
This network shows the impact of papers produced by Anna Schurich. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Schurich. The network helps show where Anna Schurich may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Anna Schurich, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 4 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 12 | |
| 4 | 2024 | 18 | |
| 5 | 2024 | 10 | |
| 6 | 2023 | 9 | |
| 7 | 2022 | 30 | |
| 8 | 2020 | 1 | |
| 9 | 2020 | 58 | |
| 10 | 2018 | 21 | |
| 11 | 2016 | 184 | |
| 12 | 2014 | 18 | |
| 13 | 2013 | 154 | |
| 14 | 2012 | 189 | |
| 15 | 2011 | 262 | |
| 16 | 2010 | 96 | |
| 17 | 2010 | 209 | |
| 18 | Adenosine regulates CD8 T cell priming by inhibition of membrane-proximal T cell receptor signaling | 2008 | 1 |
| 19 | 2008 | 79 | |
| 20 | 2005 | 4 |
About Anna Schurich
Anna Schurich is a scholar working on Immunology, Virology, Oncology, Hepatology and Epidemiology, having authored 38 papers that have together received 3.2k indexed citations. Recurring topics across this work include Immune Cell Function and Interaction (29 papers), T-cell and B-cell Immunology (11 papers), Immunotherapy and Immune Responses (10 papers), CAR-T cell therapy research (8 papers), Cytomegalovirus and herpesvirus research (6 papers), Hepatitis B Virus Studies (5 papers), Cancer Immunotherapy and Biomarkers (4 papers) and Viral gastroenteritis research and epidemiology (2 papers). The work is most often cited by research in Hepatology (1.2k citations), Immunology (1.8k citations), Epidemiology (1.6k citations), Oncology (608 citations) and Virology (85 citations). Anna Schurich has collaborated with scholars based in United Kingdom, Germany and Canada. Frequent co-authors include Mala K. Maini, Patrick Kennedy, Dimitra Peppa, Laura J. Pallett, Upkar S. Gill, L. Micco, Percy A. Knolle, Gaia Nebbia, Linda Diehl and Pooja Khanna. Their work appears in journals such as Frontiers in Immunology, Hepatology, Journal of Hepatology, Cell Reports and Molecular Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.